These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 8301764)

  • 1. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular analysis of fragile X syndrome.
    Warren ST; Nelson DL
    JAMA; 1994 Feb; 271(7):536-42. PubMed ID: 8301769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging fragile X premutation phenotype: evidence from the domain of social cognition.
    Cornish K; Kogan C; Turk J; Manly T; James N; Mills A; Dalton A
    Brain Cogn; 2005 Feb; 57(1):53-60. PubMed ID: 15629215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific methylation differences and cognitive function in fragile X premutation females.
    Allingham-Hawkins DJ; Brown CA; Babul R; Chitayat D; Krekewich K; Humphries T; Ray PN; Teshima IE
    Am J Med Genet; 1996 Aug; 64(2):329-33. PubMed ID: 8844075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-clinical correlations in males with an expanded FMR1 mutation.
    Merenstein SA; Sobesky WE; Taylor AK; Riddle JE; Tran HX; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):388-94. PubMed ID: 8844089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deletion of 1.6 Kb proximal to the CGG repeat of the FMR1 gene causes fragile X-like psychological features.
    Wiegers AM; Curfs LM; Meijer H; Oostra B; Fryns JP
    Genet Couns; 1994; 5(4):377-80. PubMed ID: 7888141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent regression of the CGG repeat in FMR1 to an allele of normal size.
    Vits L; De Boulle K; Reyniers E; Handig I; Darby JK; Oostra B; Willems PJ
    Hum Genet; 1994 Nov; 94(5):523-6. PubMed ID: 7959688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
    Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
    Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study.
    Godler DE; Slater HR; Bui QM; Storey E; Ono MY; Gehling F; Inaba Y; Francis D; Hopper JL; Kinsella G; Amor DJ; Hagerman RJ; Loesch DZ
    Clin Chem; 2012 Mar; 58(3):590-8. PubMed ID: 22235103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobehavioral characteristics of CGG amplification status in fragile X females.
    Thompson NM; Gulley ML; Rogeness GA; Clayton RJ; Johnson C; Hazelton B; Cho CG; Zellmer VT
    Am J Med Genet; 1994 Dec; 54(4):378-83. PubMed ID: 7726212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
    García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
    RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the FMR1 gene mutation to human intellectual dysfunction.
    Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB
    Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.